Quality in Care (QiC) Diabetes are the prestigious UK & Ireland awards, which since 2011 have been recognising, rewarding and sharing initiatives that improve the quality of life for people living with diabetes.
Exceptional work has been undertaken in treatment and options available for people with diabetes and/or their families/carers. The awards are a way to recognise this outstanding work.
The Department of Health and Social Care has issued a medicines supply notice (MSN) confirming that Novo Nordisk’s Tresiba® U100 FlexTouch® disposable insulin pen is expected to be out of stock within the UK from the beginning of August. This does not affect presentations of Tresiba in other devices or doses.
This MSN follows the notice earlier this week regarding a temporary shortage of the GlucaGen® (glucagon) HypoKit®.
The Department of Health and Social Care (DHSC) has published a Medicines Shortage Notification (MSN/2023/051) confirming that Novo Nordisk’s GlucaGen® (glucagon) HypoKit® is in short supply and making recommendations to healthcare professionals about action they can take as a result to support patients.
Improvement in renal function in chronic kidney disease in the first UK National Health Service (NHS) EndoBarrier service for uncontrolled diabesity
Authors:
REJ Ryder, P Sen Gupta, M Yadagiri, SP Irwin, W Burbridge, T Bashir, RA Allden, JP Bleasdale, EN Fogden, M Anderson and P Cockwell.
EndoBarrier treatment for longstanding type 2 diabetes and obesity: A comparison of the outcomes with an implantation period of 9 months versus 12 months in 90 consecutive EndoBarrier treated patients RESULTS Table 1: 78/90 (87%) patients attended review at both 9-months and 12-months after EndoBarrier implantation. Baseline characteristics: .
Authors: REJ Ryder, M Yadagiri, W Burbridge, SP Irwin, T Bashir, MC Wyres, ML Cull, JP Bleasdale, RA Allden, EN Fogden, M Anderson and P Sen Gupta.
ABCD are delighted to join Diabetes UK at their Professional Conference with a live session as part of their engaging two-day programme.
Hear from our committee members on Wednesday 26 April 2023, from 13.15 to 14.10.
Our session will be chaired by Dipesh Patel (London), ABCD Chair.
As healthcare professionals, we strive to provide the best possible care for people with type 1 diabetes. One of the most challenging aspects of managing this condition is achieving and maintaining blood glucose levels within a safe and healthy range. The development of hybrid closed-loop systems, which combine continuous glucose monitoring and insulin pump therapy with advanced algorithms to automate insulin delivery, represents a significant advance in diabetes care.
